In December 1975, the West Midlands Regional Health Authority recorded difficulties in producing sufficient plasma and it was agreed that commercial Factor 8 (Kryobulin) would need to be purchased at an annual cost to the region of £350,000.
Chronology Information
Date:
Chapter/issue
Haemophilia Centres: Policies and Practice